Oncology Institute Income Statement (2020-2025) | TOI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 48.58M49.84M52.27M52.30M55.16M60.92M64.98M71.42M76.19M80.22M82.03M85.79M94.67M98.58M99.90M100.27M104.41M119.80M136.56M
Cost of Revenue 23.09M23.57M25.39M27.35M27.38M32.88M36.13M38.38M42.81M44.88M44.96M48.36M49.50M46.52M85.53M-66.90M47.08M51.15M117.64M
Gross Profit 25.49M26.27M26.88M24.95M27.78M28.05M28.85M33.04M33.38M35.35M37.07M37.42M45.17M52.06M14.37M167.17M57.33M68.65M18.92M
Operating items
Depreciation & Amortization - Total 0.17M0.17M0.23M0.26M0.31M0.36M0.39M0.46M0.54M0.60M0.91M0.81M0.71M0.74M0.80M0.93M1.01M1.03M1.01M
Selling, General & Administrative 0.09M0.10M41.69M11.18M11.21M12.73M48.24M29.81M28.35M31.96M29.57M28.83M28.73M28.20M28.09M28.45M27.87M26.65M24.86M25.38M26.91M25.25M
Other Operating Expenses 38.99M39.58M41.48M44.63M43.51M50.52M52.72M66.47M79.69M65.83M66.84M72.18M83.47M86.33M86.31M86.41M87.93M103.07M118.36M
Operating Expenses 0.09M0.10M41.69M50.33M50.96M54.43M93.14M73.63M79.22M85.07M96.50M109.06M95.16M95.96M101.08M112.64M114.94M113.75M112.20M114.32M131.01M144.62M
Operating Income -0.19M-0.20M-7.72M-1.75M-1.12M-2.16M-40.83M-18.47M-18.30M-20.10M-25.08M-32.87M-14.94M-13.93M-15.29M-17.97M-16.36M-13.85M-11.93M-9.91M-11.21M-8.05M
EBIT -0.19M-0.20M-7.72M-1.75M-1.12M-2.16M-40.83M-18.47M-18.30M-20.10M-25.08M-32.87M-14.94M-13.93M-15.29M-17.97M-16.36M-13.85M-11.93M-9.91M-11.21M-8.05M
Non-operating items
Interest & Investment Income 0.08M0.07M0.06M0.01M0.01M1.21M1.03M0.94M
Other Non Operating Income 1.08M5.19M0.05M-0.23M0.18M0.01M15.51M8.69M3.32M-0.36M-1.28M-1.16M0.07M2.57M-0.06M0.13M-3.31M-3.99M-5.98M
Non Operating Income 1.08M5.10M0.05M28.21M37.94M12.82M17.40M13.71M2.91M-1.86M-3.36M-3.78M-1.92M0.89M-2.26M-1.25M-9.67M-5.93M-8.45M
Net income details
EBT -2.62M-2.40M-9.02M-0.78M3.98M-2.18M-12.62M19.47M-5.49M-2.70M-11.37M-29.95M-16.80M-17.28M-19.07M-19.89M-15.48M-16.11M-13.18M-19.59M-17.14M-16.50M
Tax Provisions 0.01M-0.51M0.22M0.78M0.80M-2.47M0.18M-0.03M-0.02M-0.37M0.04M0.10M0.14M-0.31M-0.13M
Profit After Tax -2.62M-2.42M-8.51M-1.00M3.21M-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M
Income from Continuing Operations -2.62M-2.42M-8.51M-1.00M3.21M-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M
Consolidated Net Income -2.62M-2.42M-8.51M-1.00M3.21M-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M
Income towards Parent Company -2.62M-2.42M-8.51M-1.00M3.21M-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M
Net Income towards Common Stockholders -2.62M-1.93M-4.00-1.00M-6.12M-0.35M-9.93M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-12.68M-13.22M-10.83M-19.59M-13.99M-13.77M
Additional items
EPS (Basic) -0.11-0.080.00-0.020.05-0.05-0.150.22-0.06-0.03-0.15-0.33-0.19-0.19-0.25-0.22-0.17-0.18-0.14-0.21-0.15-0.14
EPS (Weighted Average and Diluted) -0.080.00-0.020.05-0.05-0.150.21-0.06-0.17-0.14-0.33-0.19-0.19-0.25-0.22-0.17-0.18-0.14-0.21-0.15-0.14
Shares Outstanding (Weighted Average) 23.00M23.00M23.00M59.12M62.85M66.02M66.02M66.23M73.25M73.12M72.81M72.79M73.45M74.12M73.68M73.75M74.23M74.75M75.52M75.04M77.10M93.20M97.47M
Shares Outstanding (Diluted Average) 23.00M59.12M62.85M66.02M66.02M66.23M76.25M76.11M79.58M80.61M73.45M74.12M73.68M73.75M74.23M74.75M75.52M75.04M77.10M93.20M97.47M
EBITDA -0.19M-0.20M-7.72M-1.59M-0.94M-1.93M-40.57M-18.16M-17.95M-19.70M-24.62M-32.33M-14.34M-13.01M-14.48M-17.26M-15.62M-13.05M-11.00M-8.90M-10.18M-7.05M
Interest Expenses 0.10M0.08M0.07M0.06M1.64M1.75M1.94M1.99M2.12M2.23M1.17M5.57M1.87M1.92M
Tax Rate -0.52%5.61%-28.02%19.57%-36.63%19.55%0.92%0.58%0.89%3.23%-0.15%-0.59%-0.78%1.65%0.76%